Browse 14081 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| July 16th, 2019 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
National Institutes of Health |
| July 5th, 2019 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
National Institutes of Health |
| April 7th, 2020 |
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
National Institutes of Health |
| January 8th, 2018 |
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed |
National Institutes of Health |
| March 6th, 2019 |
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials) |
National Institutes of Health |
| January 7th, 2019 |
Bioengineering Research Partnerships (U01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 8th, 2018 |
Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2020 |
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Health Promotion Among Racial and Ethnic Minority Males (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2019 |
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional) |
National Institutes of Health |
|
| January 7th, 2020 |
Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2019 |
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2019 |
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Personalized Strategies to Manage Symptoms of Chronic Illness (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2019 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2019 |
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
National Institutes of Health |
| February 14th, 2020 |
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required) |
National Institutes of Health |
| January 22nd, 2018 |
NIH Blue Print: Development and Validation of Technologies for Rapid Isolation and Characterization of Extracellular Vesicles of Central Nervous System Origin (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2018 |
Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) |
National Institutes of Health |
